03/06/2020 /
Check out the latest updates from CURE CEO, Beth Lewin Dean.
03/04/2020 /
The Marigold Study is a pivotal Phase 3 study evaluating oral ganaxolone in children and young adults with CDKL5 Deficiency Disorder (CDD).
03/04/2020 /
The majority of TBI-, epilepsy-, and PTE-related online health education materials do not meet the sixth grade reading recommendation.
03/04/2020 /
This review aims to provide information to neurologists and epileptologists on the therapeutic value of CBD products, principally a purified form, in routine practice for patients with intractable epilepsy.
03/04/2020 /
The agency now expects to provide a decision by June 25 on whether to approve Fintepla for the treatment of seizures associated with Dravet.
03/04/2020 /
Although long-term seizure control is possible in patients who have failed prior epilepsy surgery, with each subsequent resection, the chances of success decline.
03/04/2020 /
These findings point to an active psychological process in drug-resistant patients, where approximately half generate strong positive illusions about their life with epilepsy, maintaining their mood and subjective well-being.
03/04/2020 /
DGIST joint research team identified the roles of ‘Somatostatin,’ which mediates the functions of GABAergic synaptic protein
03/03/2020 /
Neurelis is offering a VALTOCO copay assistance program through which eligible patients could pay as little as $20 for the prescription.
